PMID: 9533058Apr 9, 1998Paper

Pharmaceutical care in medical progressive care patients

The Annals of Pharmacotherapy
M A SmytheR L Begle

Abstract

To develop, implement, and assess the outcomes of a system for providing pharmaceutical care to medical progressive care patients. A system for providing pharmaceutical care was developed and implemented for an 8-week period beginning in June 1995. Both patient care outcomes and drug therapy cost change from the intervention period were compared with those of an 8-week baseline period. Variables compared included unit length of stay, hospital length of stay, transfers to the intensive care unit, readmissions, and adverse drug reactions requiring treatment. Differences between periods for these variables were assessed by using chi 2 tests and t-tests with alpha set at p less than 0.05. The clinical significance of the interventions were assessed independently by four physicians: two intensivists and two internists. The total drug therapy cost change from the intervention period was calculated as follows: total cost avoidance from individual recommendations subtracted from the total cost incurred from individual recommendations. The pharmacist evaluated 152 patients during the intervention period. A total of 235 pharmacotherapy recommendations were made on 103 patients, of whom 86.4% were accepted. Significantly fewer adverse dru...Continue Reading

References

Jun 1, 1994·Critical Care Medicine·M Montazeri, D J Cook
Jul 1, 1993·Critical Care Medicine·M A Redell

❮ Previous
Next ❯

Citations

Jan 14, 2003·Pharmacotherapy·Glen T SchumockUNKNOWN 2002 Task Force on Economic Evaluation of Clinical Pharmacy Services of the American College of Clinical Pharmacy
Nov 8, 2007·Intensive Care Medicine·Jaclyn M LeBlancJoseph F Dasta
Apr 15, 2016·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Mohamed HishamGanesh Veerasekar
Dec 10, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Thi-Ha VoUNKNOWN Working Group Standardizing and Demonstrating the Value of Clinical Pharmacy Activities of the French Society for Clinical P
May 18, 2010·Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria·M M Silva-CastroM J Faus
May 4, 2011·Journal of Clinical Pharmacy and Therapeutics·R L CastelinoM G Narahari
Sep 28, 2006·Pharmacy World & Science : PWS·Hege Salvesen BlixAsmund Reikvam
Sep 21, 2010·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Marie A Chisholm-BurnsJohn Palmer
Oct 4, 2017·Pharmacy : Journal of Pharmacy, Education and Practice·Lene Juel KjeldsenCharlotte Olesen
Jan 1, 2021·HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery·Kelly GuerinPatricia W Stone

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.